Skip to main content
. Author manuscript; available in PMC: 2020 Aug 1.
Published in final edited form as: Endocr Relat Cancer. 2019 Aug;26(8):689–698. doi: 10.1530/ERC-19-0042

Figure 1. Design-of-Experiment approaches to identify points of fragility for breast cancer targeting.

Figure 1.

Schematic depicting the proposed QbD workflow. This experimental paradigm has been previously developed by Trailhead Biosystems to assess cell-type specific differentiation from pluripotent stem cells.